BioNTech: A new malaria vaccine could be on the horizon
BioNTech plans to start clinical testing by the end of 2022 for a new malaria vaccine, which aims to make the parasite visible and attackable when it enters the body.
BioNTech plans to start clinical testing by the end of 2022 for a new malaria vaccine, which aims to make the parasite visible and attackable when it enters the body.
Zalando's new smart office in Berlin is part of a new trend of modern offices redefining workplaces.